Vanguard Group’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-7,540,469
| Closed | -$11.1M | – | 4642 |
|
2022
Q2 | $11.1M | Buy |
7,540,469
+90,313
| +1% | +$133K | ﹤0.01% | 2943 |
|
2022
Q1 | $8.57M | Buy |
7,450,156
+1,465,248
| +24% | +$1.69M | ﹤0.01% | 3236 |
|
2021
Q4 | $15M | Sell |
5,984,908
-1,873,365
| -24% | -$4.68M | ﹤0.01% | 2991 |
|
2021
Q3 | $40.2M | Sell |
7,858,273
-43,036
| -0.5% | -$220K | ﹤0.01% | 2483 |
|
2021
Q2 | $65.7M | Buy |
7,901,309
+71,331
| +0.9% | +$593K | ﹤0.01% | 2226 |
|
2021
Q1 | $68.2M | Buy |
7,829,978
+264,731
| +3% | +$2.31M | ﹤0.01% | 2138 |
|
2020
Q4 | $82.2M | Buy |
7,565,247
+224,117
| +3% | +$2.43M | ﹤0.01% | 1932 |
|
2020
Q3 | $87.6M | Buy |
7,341,130
+130,170
| +2% | +$1.55M | ﹤0.01% | 1748 |
|
2020
Q2 | $116M | Buy |
7,210,960
+223,768
| +3% | +$3.59M | ﹤0.01% | 1595 |
|
2020
Q1 | $108M | Buy |
6,987,192
+180,859
| +3% | +$2.81M | ﹤0.01% | 1482 |
|
2019
Q4 | $167M | Sell |
6,806,333
-339,060
| -5% | -$8.34M | 0.01% | 1478 |
|
2019
Q3 | $73.7M | Buy |
7,145,393
+66,923
| +0.9% | +$690K | ﹤0.01% | 1885 |
|
2019
Q2 | $88.8M | Buy |
7,078,470
+1,630,171
| +30% | +$20.5M | ﹤0.01% | 1814 |
|
2019
Q1 | $67.5M | Buy |
5,448,299
+1,805,195
| +50% | +$22.4M | ﹤0.01% | 1941 |
|
2018
Q4 | $22.4M | Sell |
3,643,104
-927,035
| -20% | -$5.71M | ﹤0.01% | 2397 |
|
2018
Q3 | $48.4M | Buy |
4,570,139
+84,726
| +2% | +$898K | ﹤0.01% | 2159 |
|
2018
Q2 | $60.8M | Buy |
4,485,413
+168,587
| +4% | +$2.28M | ﹤0.01% | 2031 |
|
2018
Q1 | $76.6M | Buy |
4,316,826
+71,143
| +2% | +$1.26M | ﹤0.01% | 1859 |
|
2017
Q4 | $53.3M | Buy |
4,245,683
+268,253
| +7% | +$3.37M | ﹤0.01% | 2035 |
|
2017
Q3 | $75.8M | Buy |
3,977,430
+557,586
| +16% | +$10.6M | ﹤0.01% | 1853 |
|
2017
Q2 | $51.6M | Buy |
3,419,844
+200,982
| +6% | +$3.03M | ﹤0.01% | 2002 |
|
2017
Q1 | $55.2M | Buy |
3,218,862
+139,066
| +5% | +$2.38M | ﹤0.01% | 1962 |
|
2016
Q4 | $37.3M | Buy |
3,079,796
+120,701
| +4% | +$1.46M | ﹤0.01% | 2119 |
|
2016
Q3 | $29.1M | Buy |
2,959,095
+132,285
| +5% | +$1.3M | ﹤0.01% | 2190 |
|
2016
Q2 | $28.9M | Buy |
2,826,810
+81,472
| +3% | +$834K | ﹤0.01% | 2164 |
|
2016
Q1 | $33.3M | Buy |
2,745,338
+1,006,908
| +58% | +$12.2M | ﹤0.01% | 2062 |
|
2015
Q4 | $27.9M | Buy |
1,738,430
+43,037
| +3% | +$689K | ﹤0.01% | 2155 |
|
2015
Q3 | $21.8M | Buy |
1,695,393
+79,053
| +5% | +$1.02M | ﹤0.01% | 2251 |
|
2015
Q2 | $38.8M | Buy |
1,616,340
+220,923
| +16% | +$5.3M | ﹤0.01% | 2068 |
|
2015
Q1 | $26.2M | Buy |
1,395,417
+306,927
| +28% | +$5.76M | ﹤0.01% | 2210 |
|
2014
Q4 | $20.5M | Buy |
1,088,490
+69,254
| +7% | +$1.31M | ﹤0.01% | 2226 |
|
2014
Q3 | $27.6M | Buy |
1,019,236
+307,504
| +43% | +$8.34M | ﹤0.01% | 2084 |
|
2014
Q2 | $22.1M | Buy |
711,732
+24,616
| +4% | +$766K | ﹤0.01% | 2177 |
|
2014
Q1 | $15.6M | Buy |
687,116
+430,775
| +168% | +$9.81M | ﹤0.01% | 2283 |
|
2013
Q4 | $5.33M | Buy |
256,341
+57,840
| +29% | +$1.2M | ﹤0.01% | 2768 |
|
2013
Q3 | $7.97M | Buy |
198,501
+189,655
| +2,144% | +$7.61M | ﹤0.01% | 2506 |
|
2013
Q2 | $249K | Buy |
+8,846
| New | +$249K | ﹤0.01% | 3612 |
|